It will support testing of "dirt to data" with sample acquisition, transport, and biomarker detection at Pasadena (in 2014 and 2016) and the Rio Tinto, Spain analog site (in 2015 and 2017). This keeps us in the game, so to speak, for another four years.
And with 8-10% selection ratios in these competitions, I had not had a major win in five years, probably 20-25 proposals submitted meanwhile. So I feel lucky today!
(high-fives my team members :-)